Literature DB >> 30104633

IgG3 regulates tissue-like memory B cells in HIV-infected individuals.

Lela Kardava1, Haewon Sohn2, Christine Youn1, James W Austin1, Wei Wang1, Clarisa M Buckner1, J Shawn Justement1, Valerie A Melson1, Gwynne E Roth2, Marissa A Hand1, Kathleen R Gittens3, Richard W Kwan3, Michael C Sneller1, Yuxing Li4,5, Tae-Wook Chun1, Peter D Sun2, Susan K Pierce2, Susan Moir6.   

Abstract

Immunoglobulin G3 (IgG3) has an uncertain role in the response to infection with and vaccination against human immunodeficiency virus (HIV). Here we describe a regulatory role for IgG3 in dampening the immune system-activating effects of chronic HIV viremia on B cells. Secreted IgG3 was bound to IgM-expressing B cells in vivo in HIV-infected chronically viremic individuals but not in early-viremic or aviremic individuals. Tissue-like memory (TLM) B cells, a population expanded by persistent HIV viremia, bound large amounts of IgG3. IgG3 induced clustering of B cell antigen receptors (BCRs) on the IgM+ B cells, which was mediated by direct interactions between soluble IgG3 and membrane IgM of the BCR (IgM-BCR). The inhibitory IgG receptor CD32b (FcγRIIb), complement component C1q and inflammatory biomarker CRP contributed to the binding of secreted IgG3 onto IgM-expressing B cells of HIV-infected individuals. Notably, IgG3-bound TLM B cells were refractory to IgM-BCR stimulation, thus demonstrating that IgG3 can regulate B cells during chronic activation of the immune system.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30104633      PMCID: PMC6289069          DOI: 10.1038/s41590-018-0180-5

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  53 in total

1.  Flexibility of human IgG subclasses.

Authors:  K H Roux; L Strelets; T E Michaelsen
Journal:  J Immunol       Date:  1997-10-01       Impact factor: 5.422

2.  A defunctioning polymorphism in FCGR2B is associated with protection against malaria but susceptibility to systemic lupus erythematosus.

Authors:  Lisa C Willcocks; Edward J Carr; Heather A Niederer; Tim F Rayner; Thomas N Williams; Wanling Yang; J Anthony G Scott; Britta C Urban; Norbert Peshu; Timothy J Vyse; Yu Lung Lau; Paul A Lyons; Kenneth G C Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-12       Impact factor: 11.205

3.  Immunoglobulin G3 from polyclonal human immunodeficiency virus (HIV) immune globulin is more potent than other subclasses in neutralizing HIV type 1.

Authors:  O Scharf; H Golding; L R King; N Eller; D Frazier; B Golding; D E Scott
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

4.  Maturational characteristics of HIV-specific antibodies in viremic individuals.

Authors:  Eric Meffre; Aaron Louie; Jason Bannock; Leo J Y Kim; Jason Ho; Cody C Frear; Lela Kardava; Wei Wang; Clarisa M Buckner; Yimeng Wang; Olivia R Fankuchen; Kathleen R Gittens; Tae-Wook Chun; Yuxing Li; Anthony S Fauci; Susan Moir
Journal:  JCI Insight       Date:  2016-03-17

5.  Structures of C1-IgG1 provide insights into how danger pattern recognition activates complement.

Authors:  Deniz Ugurlar; Stuart C Howes; Bart-Jan de Kreuk; Roman I Koning; Rob N de Jong; Frank J Beurskens; Janine Schuurman; Abraham J Koster; Thomas H Sharp; Paul W H I Parren; Piet Gros
Journal:  Science       Date:  2018-02-16       Impact factor: 47.728

6.  Independent evolution of Fc- and Fab-mediated HIV-1-specific antiviral antibody activity following acute infection.

Authors:  Anne-Sophie Dugast; Leonidas Stamatatos; Andrew Tonelli; Todd J Suscovich; Anna F Licht; Iliyana Mikell; Margaret E Ackerman; Hendrik Streeck; P J Klasse; John P Moore; Galit Alter
Journal:  Eur J Immunol       Date:  2014-08-11       Impact factor: 5.532

7.  Adaptive Immunity against Streptococcus pyogenes in Adults Involves Increased IFN-γ and IgG3 Responses Compared with Children.

Authors:  Rasmus Mortensen; Thomas Nørrelykke Nissen; Thomas Blauenfeldt; Jan P Christensen; Peter Andersen; Jes Dietrich
Journal:  J Immunol       Date:  2015-07-10       Impact factor: 5.422

8.  Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology.

Authors:  Amy W Chung; Manu P Kumar; Kelly B Arnold; Wen Han Yu; Matthew K Schoen; Laura J Dunphy; Todd J Suscovich; Nicole Frahm; Caitlyn Linde; Alison E Mahan; Michelle Hoffner; Hendrik Streeck; Margaret E Ackerman; M Juliana McElrath; Hanneke Schuitemaker; Maria G Pau; Lindsey R Baden; Jerome H Kim; Nelson L Michael; Dan H Barouch; Douglas A Lauffenburger; Galit Alter
Journal:  Cell       Date:  2015-11-05       Impact factor: 41.582

9.  Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination.

Authors:  Nicole L Yates; Hua-Xin Liao; Youyi Fong; Allan deCamp; Nathan A Vandergrift; William T Williams; S Munir Alam; Guido Ferrari; Zhi-yong Yang; Kelly E Seaton; Phillip W Berman; Michael D Alpert; David T Evans; Robert J O'Connell; Donald Francis; Faruk Sinangil; Carter Lee; Sorachai Nitayaphan; Supachai Rerks-Ngarm; Jaranit Kaewkungwal; Punnee Pitisuttithum; James Tartaglia; Abraham Pinter; Susan Zolla-Pazner; Peter B Gilbert; Gary J Nabel; Nelson L Michael; Jerome H Kim; David C Montefiori; Barton F Haynes; Georgia D Tomaras
Journal:  Sci Transl Med       Date:  2014-03-19       Impact factor: 17.956

10.  The major receptor for C-reactive protein on leukocytes is fcgamma receptor II.

Authors:  D Bharadwaj; M P Stein; M Volzer; C Mold; T W Du Clos
Journal:  J Exp Med       Date:  1999-08-16       Impact factor: 14.307

View more
  15 in total

Review 1.  B-cell abnormalities in HIV-1 infection: roles for IgG3 and T-bet.

Authors:  Lela Kardava; Susan Moir
Journal:  Curr Opin HIV AIDS       Date:  2019-07       Impact factor: 4.283

2.  Overexpression of T-bet in HIV infection is associated with accumulation of B cells outside germinal centers and poor affinity maturation.

Authors:  James W Austin; Clarisa M Buckner; Lela Kardava; Wei Wang; Xiaozhen Zhang; Valerie A Melson; Ryan G Swanson; Andrew J Martins; Julian Q Zhou; Kenneth B Hoehn; J Nicholas Fisk; Yiannis Dimopoulos; Alexander Chassiakos; Sijy O'Dell; Margery G Smelkinson; Catherine A Seamon; Richard W Kwan; Michael C Sneller; Stefania Pittaluga; Nicole A Doria-Rose; Adrian McDermott; Yuxing Li; Tae-Wook Chun; Steven H Kleinstein; John S Tsang; Constantinos Petrovas; Susan Moir
Journal:  Sci Transl Med       Date:  2019-11-27       Impact factor: 17.956

Review 3.  The antibody response in HIV-1-infected donors.

Authors:  Simone I Richardson; Penny L Moore
Journal:  Curr Opin HIV AIDS       Date:  2019-07       Impact factor: 4.283

Review 4.  Adaptive immune cell responses as therapeutic targets in antibody-mediated organ rejection.

Authors:  Kevin Louis; Camila Macedo; Carmen Lefaucheur; Diana Metes
Journal:  Trends Mol Med       Date:  2022-01-29       Impact factor: 11.951

5.  Expression of inhibitory receptors by B cells in chronic human infectious diseases restricts responses to membrane-associated antigens.

Authors:  Abhijit A Ambegaonkar; Kihyuck Kwak; Haewon Sohn; Javier Manzella-Lapeira; Joseph Brzostowski; Susan K Pierce
Journal:  Sci Adv       Date:  2020-07-24       Impact factor: 14.136

Review 6.  Women in immunology: 2020 and beyond.

Authors:  Susan K Pierce; Pamela L Schwartzberg; Nirali N Shah; Naomi Taylor
Journal:  Nat Immunol       Date:  2020-02-24       Impact factor: 25.606

Review 7.  Challenges and Opportunities for Consistent Classification of Human B Cell and Plasma Cell Populations.

Authors:  Ignacio Sanz; Chungwen Wei; Scott A Jenks; Kevin S Cashman; Christopher Tipton; Matthew C Woodruff; Jennifer Hom; F Eun-Hyung Lee
Journal:  Front Immunol       Date:  2019-10-18       Impact factor: 7.561

8.  IgG3 enhances neutralization potency and Fc effector function of an HIV V2-specific broadly neutralizing antibody.

Authors:  Simone I Richardson; Bronwen E Lambson; Andrew R Crowley; Arman Bashirova; Cathrine Scheepers; Nigel Garrett; Salim Abdool Karim; Nonhlanhla N Mkhize; Mary Carrington; Margaret E Ackerman; Penny L Moore; Lynn Morris
Journal:  PLoS Pathog       Date:  2019-12-16       Impact factor: 6.823

9.  FcγRIIb Expression Is Decreased on Naive and Marginal Zone-Like B Cells From Females With Multiple Sclerosis.

Authors:  Stephanie Trend; Jonatan Leffler; Ingrid Teige; Björn Frendéus; Allan G Kermode; Martyn A French; Prue H Hart
Journal:  Front Immunol       Date:  2021-01-11       Impact factor: 7.561

10.  T-bet+CD27+CD21- B cells poised for plasma cell differentiation during antibody-mediated rejection of kidney transplants.

Authors:  Kevin Louis; Elodie Bailly; Camila Macedo; Louis Lau; Bala Ramaswami; Alexander Chang; Uma Chandran; Douglas Landsittel; Xinyan Gu; Geetha Chalasani; Adriana Zeevi; Parmjeet Randhawa; Harinder Singh; Carmen Lefaucheur; Diana Metes
Journal:  JCI Insight       Date:  2021-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.